Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical data reported on cilengitide in NSCLC and glioblastoma

Nov. 3, 2010

Afatinib is active in patients with head and neck and lung cancers

Nov. 3, 2010

Manageable toxicity seen with brivanib alaninate plus cetuximab and irinotecan in colorectal cancer

Nov. 3, 2010

Spectrum Pharma submits additional data to FDA for Fusilev

Nov. 2, 2010

Cellceutix completes final toxicity study of Kevetrin

Nov. 2, 2010

Effects of denosumab reported in patients with prostate cancer and bone metastases

Nov. 2, 2010

FDA approves Sprycel for treatment of newly diagnosed Ph+ CML in chronic phase

Oct. 29, 2010

Astellas applies for Japanese marketing approval for degarelix for prostate cancer

Oct. 29, 2010

Combination of WX-671 and gemcitabine shows promise in phase II trial in pancreatic cancer

Oct. 29, 2010

Celator Pharma completes enrollment in phase II CPX-351 trial in AML

Oct. 28, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...